KalVista Pharmaceuticals Inc KALV Aperçu des données financières et fondamentales

Compte de résultat

Quarter End	Jan 2023	Avr 2023	Juil 2023	Oct 2023	Jan 2024	Avr 2024	Juil 2024	Oct 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Actif total	203,47M	183,2M	160,33M	138,74M	113,97M	235,4M	200,2M	160,83M
Total de l'actif circulant	192,13M	172,33M	149,84M	128,61M	104,1M	225,69M	191,63M	152,27M
Trésorerie et équivalents	85,05M	56,24M	49,41M	57,67M	23,06M	31,79M	31,85M	41,58M
Total des actifs non courants	11,34M	13,82M	2,92M	2,84M	9,87M	11,94M	2,71M	8,56M
Total des passifs	19,03M	22,18M	21M	24,3M	25,39M	28,82M	27,4M	26,84M
Total des passifs courants	11,61M	15,03M	14,13M	17,75M	19,13M	22,81M	22,41M	22,16M
Total des passifs non courants	7,42M	7,15M	6,87M	6,55M	6,26M	6,02M	4,99M	4,68M
Capitaux propres ordinaire	34k	34k	34k	34k	34k	42k	43k	43k
Bénéfices non distribués	-316,78M	-343,08M	-368,4M	-396,05M	-425,08M	-469,73M	-510,17M	-552,44M

Fin d'année 30 Avril 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Actif total	34,35M	61,39M	118,13M	92,53M	272,01M	203,88M	183,2M	235,4M
Total de l'actif circulant	34,25M	59,38M	115,55M	88,7M	264,26M	193,65M	172,33M	225,69M
Trésorerie et équivalents	30,95M	51,06M	32,01M	15,79M	50,59M	30,73M	56,24M	31,79M
Total des actifs non courants	31,33M	27,25M	96,74M	83,75M	257,19M	185,09M	161,03M	206,58M
Total des passifs	3,02M	34,14M	21,39M	8,78M	14,82M	18,79M	22,18M	28,82M
Total des passifs courants	3,02M	23,22M	18,05M	7,72M	9,77M	11,58M	15,03M	22,81M
Total des passifs non courants	0	10,98M	3,34M	1,06M	5,05M	7,21M	7,15M	6,02M
Total des capitaux propres	31,33M	27,25M	96,74M	83,75M	257,19M	185,09M	161,03M	206,58M
Capitaux propres ordinaire	10k	11k	17k	18k	24k	25k	34k	42k
Bénéfices non distribués	-55,86M	-71,66M	-92,48M	-121,59M	-167,84M	-250,18M	-343,08M	-469,73M